1.
Ann Oncol
; 35(6): 569-570, 2024 Jun.
Artículo
en Inglés
| MEDLINE
| ID: mdl-38548063
Asunto(s)
Inmunoterapia , Humanos , Inmunoterapia/efectos adversos , Inmunoterapia/métodos , Neoplasias/tratamiento farmacológico , Neoplasias/inmunología , Neoplasias/terapia , Ensayos Clínicos como Asunto , Sistemas de Registro de Reacción Adversa a Medicamentos/normas , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos/epidemiología
2.
Cancer Radiother
; 28(1): 83-92, 2024 Feb.
Artículo
en Inglés
| MEDLINE
| ID: mdl-37620212
RESUMEN
Head and neck carcinomas are initially metastatic in about 15% of cases. Radiotherapy is a cornerstone in the multimodal strategy at the locoregional phase. In patients with head and neck cancer, often heavily pretreated and with comorbidities, who relapse locoregionally or at distant sites, radiotherapy has also become increasingly important at the metastatic phase. Data on the optimal sequence of systemic treatments and metastasis-directed treatments including stereotactic irradiation are still lacking. Several randomized head and neck trials have been initiated that should provide important answers, including one recent GORTEC trial.